Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Somatropin Therapy For Short Children Born Of Premature Gestation, A Controlled, Prospective Randomized, Multicenter Study With An Untreated Control Group.

NCT00174460 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00174460
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00174460 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Somatropin Therapy For Short Children Born Of Premature Gestation, A Controlled, Prospective Randomized, Multicenter Study With An Untreated Control Group.
Lead sponsor
Pfizer
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2005
Completion date
March 31, 2010
Enrollment
33 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

growth hormone therapy, infant, very low birth weight